1/25 Early treatment study
Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study
et al., Archives of Virology, doi:10.1007/s00705-021-04956-9 (Peer Reviewed)
RCT with 44 favipiravir patients and 48 CQ patients, showing non-statistically significant lower mortality, ventilation, and hospitalization time with favipiravir.
Dabbous et al., 1/25/2021, peer-reviewed, 10 authors.
Please send us corrections, updates, or comments.